VOR BIOPHARMA INC (VOR)
US9290331084 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 52.80M | 31.36M | 57.70M | 119.80M | 48.50M | |||
| Marketable Securities | 10.01M | 105.81M | 172.50M | 87.70M | N/A | |||
| Other Current Assets | 4.49M | 3.63M | 6.70M | 6.90M | 600.00K | |||
| Total Current Assets | 67.30M | 140.80M | 237.00M | 214.40M | 49.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 43.77M | 50.10M | 57.10M | 22.50M | 21.80M | |||
| Other Non-Current Assets | 4.92M | 7.22M | 5.30M | 5.70M | 5.00M | |||
| Total Non-Current Assets | 48.70M | 57.32M | 62.40M | 28.20M | 26.80M | |||
| TOTAL ASSETS | 115.99M | 198.13M | 299.40M | 242.60M | 75.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 13.02M | 14.71M | 11.20M | 8.20M | 7.10M | |||
| Accounts Payable | 1.32M | 815.00K | 1.80M | 1.50M | 2.40M | |||
| Other Current Liabilities | 13.00K | 50.00K | 200.00K | 400.00K | 700.00K | |||
| Total Current Liabilities | 14.35M | 15.57M | 13.10M | 10.20M | 10.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 28.69M | 31.83M | 35.60M | 16.20M | 17.40M | |||
| Total Non-Current Liabilities | 28.69M | 31.83M | 35.70M | 16.10M | 17.40M | |||
| TOTAL LIABILITIES | 43.04M | 47.40M | 48.80M | 26.30M | 27.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -426.28M | -340.08M | -222.20M | -130.10M | -61.20M | |||
| Additional Paid In Capital | 499.16M | 490.87M | 473.60M | 346.40M | 2.20M | |||
| Common Shares | 7.00K | 7.00K | 0.00 | 0.00 | 107.30M | |||
| Shares Outstanding | 68.66M | 67.89M | 66.00M | 37.20M | 37.10M | |||
| Tangible Book Value per Share | 1.06 | 2.22 | 3.80 | 5.81 | -1.59 | |||
| Total Shareholders' Equity | 72.95M | 150.72M | 250.60M | 216.30M | 48.30M | |||
| TOTAL LIABILITIES AND EQUITY | 115.99M | 198.13M | 299.40M | 242.60M | 75.90M | |||
| Statistics | ||||||||
| Current Ratio | 4.69 | 9.04 | 18.09 | 21.02 | 4.81 | |||
| Return On Assets (ROA) | -96.96% | -59.49% | -30.76% | -28.91% | -64.90% | |||
| Return On Equity (ROE) | -154.15% | -78.20% | -36.75% | -32.42% | -101.99% | |||
All data in USD , ROIC based on taxRate of 0.21